Haematology & blood transfusion conference

7 February 2019

Dubai World Trade Centre

Overview:

Theme: Enabling best practice by addressing the latest trends and advances in the field of transfusion medicine

With the rapidly evolving and significant advances occurring within the field of haematology and blood transfusion, it is important to stay ahead of the curve, developing knowledge based upon science and high-quality research that supports evidence-based practice.

This scientific meeting will bring together regional and international leaders in haematology transfusion science to provide a broad overview of current key developments.

Key topics:

  • Updates and innovations in haematology and blood transfusion
  • Infection prevention and transfusion transmitted infections (TTI’s)
  • Harnessing the immune system in malignancy therapy
  • Bone marrow and coagulation

Benefits of attending

  • Review updates concerning quality control and haemovigilance improve accuracy, competence and ensure compliant practice
  • Discover key technological breakthroughs in haematology and blood transfusion to improve patient outcomes
  • Review infection control systems to reduce the occurrence of transfusion transmitted infections (TTI’s)

09:10

Opening remarks

Dr Aaron Han, Consultant Pathologist, Chief, Department of Pathology, American Hospital Dubai, Dubai, UAE

Dr Ziad Peerwani, Acting Chairman, Pathology and Laboratory Medicine, Consultant, Hematopathologist, Tawam Hospital, Abu Dhabi, UAE


Session 1

Updates and innovations in Haematology and Blood Transfusion

09:20

Special address: Blood group matching in the genomic era

Prof Martin L. Olsson, President, International Society of Blood Transfusion, Professor, Transfusion Medicine, Vice Dean, Faculty of Medicine, Lund University, Lund, Sweden

10:00

Quality practices in the Haematology laboratory

Dr Bharati Jhaveri, Clinical Professor of Pathology, Southern Illinois School of Medicine, International Deputy Regional Commissioner, Inspector, College of American Pathologists (CAP) Springfield, Illinois, USA

10:30

Controlling disease complications of Thalassaemia Major for improved survival and quality of life

Prof Soad Khalil Al Jaouni, Hematology, Pediatric Hematology Oncology, Deputy Chair of Hematology Department, Head Division of Pediatric Hematology /Oncology, Department of Hematology, Faculty of Medicine, King Abdulaziz University, President & Founder, Saudi Society of Hematology, Jeddah, KSA

11:00

Updates in blood banking: opportunities and challenges

Dr Khawla Belhol, Head, Thalassemia Center, Dubai Health Authority, Dubai, UAE

11:30 Coffee Break


Session 2

Infection Prevention and Transfusion Transmitted Infections (TTI’s)

12:00

Effectively addressing post transfusion complications: Transfusion associated graft versus host disease (GVHD)

Dr Suzanne Bakdash, Pathologist, Blood banking and Transfusion Medicine Specialist, Clinical Pathology, Cleveland Clinic Ohio, Cleveland, USA

12:30

Diagnosis of blood transmitted viruses

Prof Dr Heinz Zeichhardt, Professor of Virology (retired), EQAS Scheme Advisor for Virology, Charité – University Medicine Berlin, Campus Benjamin Franklin, Institute of Virology, Berlin, Germany

13:00 Lunch Break


Session 3

Harnessing the Immune System in Malignancy Therapy

14:00

CAR-T therapy within hematologic malignancies

Speaker tbc

14:30

Interactive Q & A


Session 4

Bone Marrow and Coagulation

15:00

Effect of NOACS and DOACS on coagulation assays - Laboratories need to be aware

Dr Ziad Peerwani, Acting Chairman, Pathology and Laboratory Medicine, Consultant, Hematopathologist, Tawam Hospital, Abu Dhabi, UAE

15:30

Monocytes, their role in sepsis pathogenesis, and new diagnostic opportunities.

Dr Elena A Sukhacheva, Senior Manager, Global Medicaland Scientific Affairs, Beckman Coulter Eurocenter, Nyon, Switzerland

16:00 Coffee break

16:30

Effectively addressing bone marrow failure syndrome

Dr Abdul Hafeez Siddiqui, Consultant Paediatric Haematologist/Oncologist, American Hospital, Dubai, UAE

17:00

Molecular and genetic drivers in Acute Myeloid Leukemia

Dr Chethan Belludi, Consultant Physician, Clinical Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE

17:30

Minimal residual disease in acute leukemia

Dr Ahmad Alduaij, Staff Physician, Anatomical Pathology, Pathology & Laboratory Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

18:00

Closing remarks

18:05 End of conference

Co-chairs:

Dr Aaron Han, Consultant Pathologist, Chief, Department of Pathology, American Hospital Dubai, Dubai, UAE
Dr Ziad Peerwani, A/ Chairman, Pathology and Laboratory Medicine, Consultant, Hematopathologist, Tawam Hospital, Abu Dhabi, UAE


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA


Speaker faculty:

 

Dr Abdul Hafeez Siddiqui, Consultant Paediatric Haematologist/Oncologist, American Hospital, Dubai, UAE

Dr Ahmad Alduaij, Staff Physician, Anatomical Pathology, Pathology & Laboratory Medicine, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE

Dr Bharati Jhaveri, Clinical Professor of Pathology, Southern Illinois School of Medicine, International Deputy Regional Commissioner, Inspector, College of American Pathologists (CAP) Springfield, Illinois, USA

Dr Chethan Belludi, Consultant Physician, Clinical Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Dr Elena A Sukhacheva, Senior Manager, Global Medical and Scientific Affairs, Beckman Coulter Eurocenter, Nyon, Switzerland

Prof Dr Heinz Zeichhardt, Professor of Virology (retired), EQAS Scheme Advisor for Virology, Charité – University Medicine Berlin, Campus Benjamin Franklin, Institute of Virology, Berlin, Germany

Dr Khawla Belhol, Head, Thalassemia Center, Dubai Health Authority, Dubai, UAE

Prof Martin L. Olsson, President, International Society of Blood Transfusion, Professor, Transfusion Medicine, Vice Dean, Faculty of Medicine, Lund University, Lund, Sweden

Dr Suzanne Bakdash, Pathologist, Blood banking and Transfusion Medicine Specialist, Clinical Pathology, Cleveland Clinic Ohio, Cleveland, USA

Prof Soad Khalil Al Jaouni, Hematology, Pediatric Hematology Oncology, Deputy Chair of Hematology Department, Head Division of Pediatric Hematology /Oncology, Department of Hematology, Faculty of Medicine, King Abdulaziz University, President & Founder, Saudi Society of Hematology, Jeddah, KSA


Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


Provided by: